// A trace of one run of agent/propose.py, for the demo page (format in ../README.md). Generated: do not edit by hand.
(window.DEMO_RUNS = window.DEMO_RUNS || []).push({
  "id": "kit-imatinib",
  "query": "Does imatinib inhibit the KIT kinase, and how potently?",
  "model": "deepseek-ai/DeepSeek-V4.1-Flash-1017",
  "mock": false,
  "note": "Graphs: hand-written sample (agent/data/sample_kg)",
  "lookup": {
    "tool": "kb.search",
    "args": {
      "compound": "imatinib",
      "target": "KIT"
    },
    "verdict": "I don’t know",
    "result": "No measured activity for imatinib against KIT (mast/stem cell growth factor receptor) in the knowledge base.",
    "rows": [],
    "note": "No measurement for this pair in the knowledge base: the agent must propose the experiment, not the answer."
  },
  "calls": [
    {
      "tool": "bio_kg.resolve",
      "args": {
        "compound": "imatinib",
        "target": "KIT"
      },
      "summary": "Both entities found; the target belongs to a class with protocol templates.",
      "rows": [
        [
          "CHEMBL941",
          "Compound",
          "imatinib"
        ],
        [
          "P10721",
          "Target",
          "KIT (mast/stem cell growth factor receptor)"
        ],
        [
          "class:tyrosine_kinase",
          "TargetClass",
          "tyrosine kinase"
        ]
      ],
      "columns": [
        "ID",
        "Type",
        "Name"
      ]
    },
    {
      "tool": "bio_kg.analogs",
      "args": {
        "compound": "imatinib",
        "target": "KIT",
        "k": 5
      },
      "summary": "3 compound(s) with measured activity on KIT: IC50 from 20 nM to 200 nM.",
      "rows": [
        [
          "nilotinib (CHEMBL255863)",
          "0.71",
          "200 nM"
        ],
        [
          "dasatinib (CHEMBL1421)",
          "0.38",
          "20 nM"
        ],
        [
          "sunitinib (CHEMBL535)",
          "0.29",
          "50 nM"
        ]
      ],
      "columns": [
        "Compound",
        "Similarity",
        "IC50 on KIT"
      ]
    },
    {
      "tool": "protocol_kg.templates",
      "args": {
        "question_type": "potency",
        "target_class": "class:tyrosine_kinase"
      },
      "summary": "One template fits a potency question on this target class.",
      "rows": [
        [
          "proto:kinase_glo",
          "Protocol",
          "biochemical kinase inhibition, luminescence readout"
        ],
        [
          "BAO:0000357",
          "Format",
          "single protein format"
        ],
        [
          "BAO:0000190",
          "Endpoint",
          "IC50"
        ],
        [
          "readout:luminescence",
          "Readout",
          "luminescence"
        ],
        [
          "reagent:dmso",
          "Vehicle control",
          "DMSO vehicle"
        ],
        [
          "reagent:staurosporine",
          "Positive control",
          "staurosporine (positive control)"
        ],
        [
          "labware:plate96",
          "Plate",
          "corning_96_wellplate_360ul_flat"
        ]
      ],
      "columns": [
        "ID",
        "Type",
        "Name"
      ]
    }
  ],
  "reasoning": [
    "I'll start by resolving imatinib and KIT to their knowledge-graph nodes to get the target class.",
    "Imatinib (CHEMBL941) and KIT (P10721) resolve to a tyrosine kinase class with templates; next I'll pull similar compounds with measured KIT activity to set the potency range.",
    "Analog IC50s span 20–200 nM, so I need a series covering ~1 nM to ~30 µM; now I'll fetch the potency template for tyrosine kinases.",
    "The template gives Kinase-Glo, 1:3, 10 points, 3 replicates with DMSO and staurosporine controls; I'll raise the top to 30 µM so the series brackets 20–200 nM with a full plateau.",
    "Similar kinase inhibitors inhibit KIT at 20-200 nM, so a 1:3 series from 30 µM brackets that range with points on both sides and a saturating top. Kinase-Glo on recombinant KIT domain yields a direct IC50."
  ],
  "thinking": [
    "",
    "Now get analogs.",
    "Analog IC50s: 20–200 nM. Expected potency ~20–200 nM. Need series bracketing with at least two points on each side and reaching top plateau.\n\nDesign: top concentration 100 µM? That's very high relative to 20-200 nM. Let's think: with 1:3 dilution, 10 points from 100 µM: 100, 33.3, 11.1, 3.7, 1.23, 0.41, 0.137, 0.0457, 0.0152, 0.005 µM. That brackets 0.02–0.2 µM well: points below 0.02: 0.0152, 0.005 (two below); points above 0.2: 0.41, 1.23, 3.7, 11.1, 33.3, 100. Top plateau reached since 100 µM is 500× the highest analog IC50. That works.\n\nAlternatively top 10 µM with 1:3, 10 points: 10, 3.33, 1.11, 0.37, 0.123, 0.041, 0.0137, 0.0046, 0.0015, 0.0005. Brackets 0.02–0.2: below 0.02: 0.0137, 0.0046, 0.0015, 0.0005 (four below); above 0.2: 0.37, 1.11, 3.33, 10. Top 10 µM = 50× highest analog IC50 — plateau likely but 100 µM safer for full inhibition plateau. Hmm, but 100 µM imatinib may be solubility-limited. Typical biochemical kinase assays use top 10 µM or 30 µM. I'll go with 30 µM top, 1:3, 10 points: 30, 10, 3.33, 1.11, 0.37, 0.123, 0.041, 0.0137, 0.0046, 0.0015. Brackets: above 0.2: 0.37, 1.11, 3.33, 10, 30 (five); below 0.02: 0.0137, 0.0046, 0.0015 (three). Good. Top 30 µM = 150× highest analog IC50 → plateau.\n\nI'll use 30 µM, 1:3, 10 points. Now get protocol template.",
    "Template: Kinase-Glo, 1:3, 10 points, 3 replicates, DMSO vehicle + staurosporine positive control, top default 10 µM. But analogs go up to 200 nM; 10 µM top = 50× highest analog IC50 — plateau likely. But to be safe and reach plateau, 30 µM gives 150×. The instruction: derive top concentration from analog IC50s. 30 µM with 1:3, 10 points gives 3 points below 20 nM and 5 above 200 nM. That's good. I'll use 30 µM.\n\nNow propose.",
    ""
  ],
  "proposal": {
    "question_id": "kit-imatinib",
    "answerable_from_kb": false,
    "answer": null,
    "experiment": {
      "assay_type": "biochemical kinase inhibition (dose-response)",
      "readout": "luminescence (ATP-consumption, Kinase-Glo)",
      "system": "recombinant KIT kinase domain",
      "top_concentration_uM": 30.0,
      "dilution_factor": 3.0,
      "n_points": 10,
      "replicates": 3,
      "controls": [
        "DMSO vehicle control",
        "staurosporine positive control"
      ]
    },
    "rationale": "Similar kinase inhibitors inhibit KIT at 20-200 nM, so a 1:3 series from 30 µM brackets that range with points on both sides and a saturating top. Kinase-Glo on recombinant KIT domain yields a direct IC50.",
    "citations": [
      "CHEMBL941",
      "P10721",
      "class:tyrosine_kinase",
      "CHEMBL255863",
      "CHEMBL1421",
      "CHEMBL535",
      "proto:kinase_glo",
      "BAO:0000357",
      "BAO:0000190",
      "reagent:dmso",
      "reagent:staurosporine"
    ],
    "model": "deepseek-ai/DeepSeek-V4.1-Flash-1017"
  },
  "plate": {
    "rows": "ABC",
    "top_uM": 30.0,
    "factor": 3.0,
    "points": 10,
    "controls": {
      "11": "DMSO",
      "12": "positive"
    }
  }
});
